[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]TreeFrog Therapeutics today joins the Japanese Society for Regenerative Medicine (JSRM). Already present in Japan with a local Business Development Officer - Etsuko Takanashi - the French company intends to set up a hub demonstrating its C-Stem technology...

Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M€ as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and investor...

Today, Andrea Leonoard, Senior Scientist at TreeFrog Therapeutics was in London, UK to speak at the 3D Cell Culture Conference. She gave an invited presentation about the C-Stem™, our 3D technology for stem cell mass-production.    ...

Today, Maxime Feyeux, President and CSO of TreeFrog Therapeutics, presented the C-Stem™ technology at the Regenerative Medicine Crossroad in Tokyo #11 conference! ...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space][vc_column_text] Senior profiles from Merck KGaA and FUJIFILM Cellular Dynamics join in to accelerate the global dissemination of proprietary C-StemTM technology for cell therapy mass-production.   Bordeaux, France, February 5, 2020 – TreeFrog Therapeutics, a pure player in iPSC-derived cell therapies,...

TreeFrog Therapeutics was selected to join the French Tech 120 !   Launched by the French government, this program dedicated to startups in the hyper-growth phase offers unprecedented support to 123 fast-growing companies. By pooling the skills of numerous government agencies, ministries and public services, the French...